SCHEMBL7303736

SCHEMBL7303736

CC(C)(C)OC(=O)N(CCCCC(=O)O)C1CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ALDH1A1 P00352 2/20 0.36
CA14 Q9ULX7 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
KDM5A P29375 4/20 0.34
PHF8 Q9UPP1 4/20 0.34
KDM2A Q9Y2K7 4/20 0.34
KDM4C Q9H3R0 3/20 0.34
KDM7A Q6ZMT4 1/20 0.34
LMNA P02545 2/20 0.33
EPHX2 P34913 1/20 0.33
TSHR P16473 3/20 0.32
AKR1B1 P15121 1/20 0.32
NFKB1 P19838 1/20 0.32
PMP22 Q01453 1/20 0.32
KDM4A O75164 1/20 0.32
CCR5 P51681 1/20 0.32
HSD11B1 P28845 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25031523 0.93 HDAC1 (0.37) HDAC1HDAC2HDAC6ALDH1A1CA14
SCHEMBL6498594 0.89 CA14 (0.34) HDAC1HDAC2HDAC6CA14L3MBTL1
SCHEMBL31645036 0.88 CA14 (0.33) HDAC1HDAC2HDAC6ALDH1A1CA14
SCHEMBL25756042 0.86 HDAC1 (0.32) HDAC1HDAC2HDAC6ALDH1A1L3MBTL1
SCHEMBL25755991 0.86 HDAC1 (0.32) HDAC1HDAC2HDAC6ALDH1A1L3MBTL1
SCHEMBL25031556 0.86 HDAC1 (0.32) HDAC1HDAC2HDAC6ALDH1A1L3MBTL1
SCHEMBL6497822 0.84 BTK (0.38) HDAC1HDAC2HDAC6CA14KDM5A
SCHEMBL4711748 0.84 CA14 (0.39) HDAC1HDAC2HDAC6CA14L3MBTL1
SCHEMBL6486048 0.83 BTK (0.37) L3MBTL1KDM5APHF8KDM2AKDM4C
SCHEMBL2082167 0.83 CA14 (0.35) HDAC1HDAC2HDAC6CA14L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0559046-B1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors HOFFMANN LA ROCHE (CH) 2001-07-11 EP disclosed
EP-0559046-A1 N-amidinopiperidinyl(3/4)- or N-amidino-1,4-Oxazinyl(2)-substituted sulfonamides, process for their preparation and use as thrombin inhibitors F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT (CH) 1993-09-08 EP disclosed